Expression subtypes of lung adenocarcinoma and squamous cell carcinoma reveal a varied immune landscape and unique somatic genetic features suggesting differential response to multiple drug targets. (December 2016) - Faruki, H.; Mayhew, G.; Hayes, N.; Serody, J.; Perou, C.; Lai-Goldman, M.